Rare pulmonary disease Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

🩺

16Specialists

Regulatory Watchboard

1 event

Apr 2015A National Registry For Pulmonary Alveolar Proteinosis

Children's Hospital Medical Center, Cincinnati

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Rare pulmonary disease.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Dupixent

(dupilumab)Orphan drugstandard

Regeneron Pharmaceuticals, Inc.

Interleukin-4 Receptor alpha Antagonist [EPC]

12.1 Mechanism of Action Dupilumab is a human monoclonal IgG4 antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling by spec...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare pulmonary disease.
Search all trials →

Search clinical trials for Rare pulmonary disease →

Recent News & Research

No recent news articles indexed yet for Rare pulmonary disease.
Search PubMed for Rare pulmonary disease →

Browse all Rare pulmonary disease news →

Specialist Network

Top 6 by expertise

Matthew Krebs, Dr

The Christie Hospital

Score 387 trials

Lillian Siu, MD

Princess Margaret Hospital, Canada

Score 1213 trials

Morgan Lam

ArriVent BioPharm

Score 113 trials9 pubs

Thomas Cash, MD, M.D

Emory University

📍 BIRMINGHAM, AL

Score 83 trials

Si-Yu Wang, MD

Sun Yat-sen University

Score 83 trials

Philippe Bedard, MD, D.M.D

Princess Margaret Hospital, Canada

📍 BROOKLYN, NY

Score 83 trials

View all Rare pulmonary disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰